The workshop is organised by the International Society for the Study of Xenobiotics (ISSX) and the audience will include scientists from academia, industry, and governmental and regulatory agencies. The two-day workshop will address critical challenges in predicting human clearance and pharmacokinetics which are essential components of drug discovery and development and include speakers from Eli Lilly, Pfizer and Merck.

For more information visit the ISSX conference web site